OVIT (OncoVista Innovative Therapies) Accounts Payable: $1.97 Mil (As of Sep. 2015)


What is OncoVista Innovative Therapies Accounts Payable?

OncoVista Innovative Therapies OVIT Accounts Payable is $1.97 Mil as of Sep. 2015.

OncoVista Innovative Therapies's Accounts Payable for the quarter that ended in Sep. 2015 was $1.97 Mil.

OncoVista Innovative Therapies's quarterly Accounts Payable increased from Mar. 2015 ($1.75 Mil) to Jun. 2015 ($1.83 Mil) and increased from Jun. 2015 ($1.83 Mil) to Sep. 2015 ($1.97 Mil).

OncoVista Innovative Therapies's annual Accounts Payable increased from Dec. 2012 ($0.93 Mil) to Dec. 2013 ($1.27 Mil) and increased from Dec. 2013 ($1.27 Mil) to Dec. 2014 ($1.67 Mil).

OncoVista Innovative Therapies Accounts Payable Related Terms

OncoVista Innovative Therapies Accounts Payable Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Accounts Payable Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.82 0.93 1.27 1.67

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 1.67 1.75 1.83 1.97

OncoVista Innovative Therapies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.97 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Accounts Payable of $1.97 Mil as of Sep. 2015. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Accounts Payable too high?
OncoVista Innovative Therapies' current Accounts Payable is $1.97 Mil.
How does OncoVista Innovative Therapies' Accounts Payable compare to RSPI and HSTC?
OncoVista Innovative Therapies' Accounts Payable of $1.97 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Accounts Payable is $1.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Accounts Payable of $1.97 Mil. The current Accounts Payable is $1.97 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Accounts Payable is $1.97 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.